GSK’s candidate Shingles Vaccine Containing Agenus’ QS-21 Stimulon® Demonstrates 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Yea
Go back to GSK’s candidate Shingles Vaccine Containing Agenus’ QS-21 Stimulon® Demonstrates 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Yea| AGENUS (NASDAQ: AGEN) | Delayed: 7.43 -0.81 (9.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.24 | 52 Week High | $7.49 | |||
| Open | $8.14 | 52 Week Low | $2.61 | |||
| Day High | $8.18 | P/E | N/A | |||
| Day Low | $7.42 | EPS | $-1.10 | |||
| Volume | 1,207,565 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 48.54 -1.35 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.89 | 52 Week High | $45.58 | |||
| Open | $49.00 | 52 Week Low | $37.82 | |||
| Day High | $49.23 | P/E | N/A | |||
| Day Low | $48.54 | EPS | $0.00 | |||
| Volume | 3,062,278 | |||||

